---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-170512"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2025-07-31T23:59:59+00:00"
generated_at: "2026-05-17T22:43:10.550531+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ResMed Q4 revenue up 10% to $1.35B, EPS $2.58; dividend raised 13% to $0.60

## Summary
- Q4 revenue $1.35B (+10% YoY, +9% CC); GAAP EPS $2.58 (+30%), non-GAAP EPS $2.55 (+23%).
- Gross margin up 230bps to 60.8% GAAP; operating income $454.5M (+19%).
- FY2025 revenue $5.15B (+10%); GAAP EPS $9.51 (+37%).
- Dividend raised 13% to $0.60/share; payable Sept 18, record Aug 14; ex-div Aug 13.

## SEC filing metadata
- accession: 0001193125-25-170512
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2025-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312525170512/0001193125-25-170512-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312525170512/d926247d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-170512
- JSON: https://secwatch.observer/filing/0001193125-25-170512.json
- Plain text: https://secwatch.observer/filing/0001193125-25-170512.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.